[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ZA937313B - Process for obtaining 10-deacetylbaccatin III - Google Patents

Process for obtaining 10-deacetylbaccatin III

Info

Publication number
ZA937313B
ZA937313B ZA937313A ZA937313A ZA937313B ZA 937313 B ZA937313 B ZA 937313B ZA 937313 A ZA937313 A ZA 937313A ZA 937313 A ZA937313 A ZA 937313A ZA 937313 B ZA937313 B ZA 937313B
Authority
ZA
South Africa
Prior art keywords
obtaining
deacetylbaccatin iii
taxus
yew
extraction
Prior art date
Application number
ZA937313A
Other languages
English (en)
Inventor
Jean-Claude Gaullier
Bernadette Mandard
Rodolphe Margraff
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of ZA937313B publication Critical patent/ZA937313B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrane Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
ZA937313A 1992-10-05 1993-10-01 Process for obtaining 10-deacetylbaccatin III ZA937313B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9211746A FR2696463B1 (fr) 1992-10-05 1992-10-05 Procédé d'obtention de la désacétyl-10 baccatine III.

Publications (1)

Publication Number Publication Date
ZA937313B true ZA937313B (en) 1994-04-25

Family

ID=9434124

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA937313A ZA937313B (en) 1992-10-05 1993-10-01 Process for obtaining 10-deacetylbaccatin III

Country Status (30)

Country Link
US (1) US5393895A (sk)
EP (1) EP0663910B1 (sk)
JP (1) JP3299754B2 (sk)
KR (1) KR100301236B1 (sk)
CN (1) CN1043530C (sk)
AT (1) ATE148883T1 (sk)
AU (1) AU680629B2 (sk)
CA (1) CA2146373C (sk)
CZ (2) CZ284615B6 (sk)
DE (1) DE69308155T2 (sk)
DK (1) DK0663910T3 (sk)
EE (1) EE03126B1 (sk)
ES (1) ES2098061T3 (sk)
FI (1) FI109794B (sk)
FR (1) FR2696463B1 (sk)
GE (1) GEP20001937B (sk)
GR (1) GR3022617T3 (sk)
HU (1) HU226862B1 (sk)
LT (1) LT3398B (sk)
LV (1) LV10621B (sk)
MX (1) MX9305771A (sk)
NO (1) NO310413B1 (sk)
NZ (1) NZ256450A (sk)
PL (1) PL177316B1 (sk)
RU (1) RU2107065C1 (sk)
SK (1) SK280949B6 (sk)
TW (1) TW255890B (sk)
UA (1) UA44227C2 (sk)
WO (1) WO1994007882A1 (sk)
ZA (1) ZA937313B (sk)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2696462B1 (fr) * 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé d'obtention de la désacétyl-10 baccatine III.
ATE420628T1 (de) 1993-07-19 2009-01-15 Angiotech Pharm Inc Anti-angiogene mittel und verfahren zu deren verwendung
WO1995012445A1 (de) * 1993-11-02 1995-05-11 Rhône-Poulenc Rorer GmbH Verfahren und vorrichtung zum auftrennen eines gemisches
FR2714053B1 (fr) * 1993-12-22 1996-03-08 Pf Medicament Procédé d'extraction et d'isolement de la 10-désacétylbaccatine III.
CN1112433A (zh) * 1994-05-24 1995-11-29 郭明 红豆杉属植物提取物及其应用
CA2178541C (en) 1995-06-07 2009-11-24 Neal E. Fearnot Implantable medical device
FR2736355B1 (fr) * 1995-07-07 1997-11-07 Pf Medicament Procede d'extraction et d'isolement de la 10-desacetylbaccatine iii
US5750736A (en) * 1996-07-11 1998-05-12 Napro Biotherapeutics, Inc. Method for acylating 10-deacetylbaccatin III selectively at the c-10 position
US5965752A (en) * 1996-08-23 1999-10-12 Institut National De La Recherche Scientifique Preparative scale isolation and purification of taxanes
CN1246277C (zh) * 1997-08-21 2006-03-22 佛罗里达州立大学 紫杉烷类化合物的合成方法
US6002024A (en) * 1998-07-27 1999-12-14 Dabur Research Foundation Process for the isolation of 14β-hydroxy-10-deacetyl baccatin-III
US6136989A (en) * 1998-12-30 2000-10-24 Phytogen Life Sciences, Incorporated Method for high yield and large scale extraction of paclitaxel from paclitaxel-containing material
US6495705B2 (en) 2000-03-16 2002-12-17 Napro Biotherapeutics, Inc. Efficient process for the production of 10-DAB III by selective hydrazinolysis of various taxanes
US6281368B1 (en) 2000-03-16 2001-08-28 Napro Biotherapeutics, Inc. Simple and efficient hydrazinolysis of C-10 and C-13 ester functionalities of taxanes to obtain 10-DAB III
CA2307393A1 (en) 2000-05-01 2001-11-01 The University Of British Columbia Ginsenoside chemotherapy
WO2002072150A2 (en) 2001-03-13 2002-09-19 Angiotech Pharmaceuticals Inc. Micellar drug delivery vehicles and uses thereof
US20030157170A1 (en) * 2001-03-13 2003-08-21 Richard Liggins Micellar drug delivery vehicles and precursors thereto and uses thereof
NZ529647A (en) * 2001-04-20 2007-05-31 Univ British Columbia Micellar drug delivery systems for hydrophobic drugs
US7351542B2 (en) 2002-05-20 2008-04-01 The Regents Of The University Of California Methods of modulating tubulin deacetylase activity
CA2511521C (en) 2002-12-30 2012-02-07 Angiotech International Ag Drug delivery from rapid gelling polymer composition
CN101039957A (zh) 2003-05-16 2007-09-19 因特缪恩公司 合成的趋化因子受体配体及其使用方法
US8003122B2 (en) 2004-03-31 2011-08-23 Cordis Corporation Device for local and/or regional delivery employing liquid formulations of therapeutic agents
US7846940B2 (en) 2004-03-31 2010-12-07 Cordis Corporation Solution formulations of sirolimus and its analogs for CAD treatment
US7989490B2 (en) 2004-06-02 2011-08-02 Cordis Corporation Injectable formulations of taxanes for cad treatment
WO2006014345A1 (en) * 2004-07-02 2006-02-09 Ivax Pharmaceuticals S.R.O. Process for the separation of paclitaxel and cephalomannin
US7597884B2 (en) 2004-08-09 2009-10-06 Alios Biopharma, Inc. Hyperglycosylated polypeptide variants and methods of use
US20060188508A1 (en) 2005-02-17 2006-08-24 Cohen Stanley N Methods and compositions for modulating angiogenesis
WO2007062036A2 (en) 2005-11-21 2007-05-31 Med Institute, Inc. Implantable medical device coatings with biodegradable elastomer and releasable therapeutic agent
US8168216B2 (en) 2006-03-22 2012-05-01 Medigene Ag Treatment of triple receptor negative breast cancer
EP2380606B1 (en) 2006-06-30 2018-03-21 Cook Medical Technologies LLC Methods of manufacturing and modifying taxane coatings for implantable medical devices
US8420110B2 (en) 2008-03-31 2013-04-16 Cordis Corporation Drug coated expandable devices
US8409601B2 (en) 2008-03-31 2013-04-02 Cordis Corporation Rapamycin coated expandable devices
US8273404B2 (en) 2008-05-19 2012-09-25 Cordis Corporation Extraction of solvents from drug containing polymer reservoirs
ES2530462T3 (es) 2008-05-22 2015-03-03 Galera Therapeutics Llc Combinación terapia antitumoral
US20110172293A1 (en) 2008-07-08 2011-07-14 Fish Jason E Methods and Compositions for Modulating Angiogenesis
US8642063B2 (en) 2008-08-22 2014-02-04 Cook Medical Technologies Llc Implantable medical device coatings with biodegradable elastomer and releasable taxane agent
US20120302954A1 (en) 2011-05-25 2012-11-29 Zhao Jonathon Z Expandable devices coated with a paclitaxel composition
US20120303115A1 (en) 2011-05-25 2012-11-29 Dadino Ronald C Expandable devices coated with a rapamycin composition
CN104039771B (zh) 2011-09-26 2017-10-27 Kabi费森尤斯肿瘤学有限公司 包括c(7)‑oh和c(13)‑oh甲硅烷基化或仅c(7)‑oh甲硅烷基化的用于制备卡巴他赛的方法
US9956385B2 (en) 2012-06-28 2018-05-01 The Spectranetics Corporation Post-processing of a medical device to control morphology and mechanical properties
EP3539563A1 (en) 2012-07-19 2019-09-18 Redwood Bioscience, Inc. Antibody specific for cd22 and methods of use thereof
EP2916835A4 (en) 2012-11-12 2016-07-27 Redwood Bioscience Inc COMPOUNDS AND METHOD FOR PRODUCING A CONJUGATE
CN103804326A (zh) * 2012-11-15 2014-05-21 刘胜远 一种从含10-去乙酰基巴卡亭ⅲ的浸膏分离和提纯10-去乙酰基巴卡亭ⅲ的方法
EP3613439B1 (en) 2013-02-15 2021-04-07 The Regents Of The University Of California Chimeric antigen receptor and methods of use thereof
CN103145652B (zh) * 2013-03-05 2015-09-30 无锡尔云科技有限公司 一种从红豆杉属植物中提取紫杉醇及其衍生物的方法
WO2014160185A2 (en) 2013-03-14 2014-10-02 The Board Of Trustees Of The Leland Stanford Junior University Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof
CN105744935B (zh) 2013-11-27 2022-09-30 雷德伍德生物科技股份有限公司 肼基-吡咯并化合物及用于生成缀合物的方法
KR102319882B1 (ko) 2014-02-19 2021-11-03 아비브 테라퓨틱스, 인크. 암의 치료를 위한 폴리사이클릭 아미드와 결합하는 미토콘드리아 알데히드 탈수소효소 2 (aldh2) 및 그의 용도
EP3352796A4 (en) 2015-09-25 2019-05-01 ZY Therapeutics Inc. PARTICLE-BASED MEDICINAL FORMULATION COMPRISING A POLYSACCHARIDE-VITAMIN CONJUGATE
EP3373977A4 (en) 2015-11-12 2019-07-17 The Board of Trustees of the Leland Stanford Junior University CELLULAR PENETRATION-RICH GUANIDINIC OLIGOPHOSPHOTRIESTERS FOR THE DELIVERY OF MEDICATION AND PROBE
TWI760319B (zh) 2015-12-30 2022-04-11 杏國新藥股份有限公司 乳癌治療
EP3448885A4 (en) 2016-04-26 2020-01-08 R.P. Scherer Technologies, LLC ANTIBODY CONJUGATES AND METHODS OF MAKING AND USING SAME
HUE057856T2 (hu) 2016-06-01 2022-06-28 Servier Ip Uk Ltd Polialkilén-oxid-aszparagináz készítményei és eljárás ezek elõállítására és alkalmazására
TWI852903B (zh) 2017-01-05 2024-08-21 杏國新藥股份有限公司 胰臟癌治療
CN110177808A (zh) 2017-01-18 2019-08-27 F1肿瘤医学公司 针对axl或ror2的嵌合抗原受体及其使用方法
EP3388082A1 (en) 2017-04-13 2018-10-17 Galera Labs, LLC Combination cancer immunotherapy with pentaaza macrocyclic ring complex
US20210338686A1 (en) 2018-01-31 2021-11-04 Galera Labs, Llc Combination cancer therapy with pentaaza macrocyclic ring complex and platinum-based anticancer agent
BR112020020930A2 (pt) 2018-04-11 2021-03-02 Ohio State Innovation Foundation composição de liberação de fármaco, método para tratar um distúrbio oftalmológico e kit
CN108904137A (zh) * 2018-05-27 2018-11-30 肖军威 一种卫生巾芯片的制备方法及卫生巾芯片的加工设备
CA3105879A1 (en) 2018-07-18 2020-01-23 Manzanita Pharmaceuticals, Inc. Conjugates for delivering an anti-cancer agent to nerve cells, methods of use and methods of making thereof
TW202038994A (zh) 2019-01-14 2020-11-01 美商醫格耐免疫治療公司 重組痘瘡病毒及其使用方法
JP2022520220A (ja) 2019-02-14 2022-03-29 イグナイト イミュノセラピー インク 組換えワクシニアウイルスおよびその使用方法
US20220204627A1 (en) 2019-04-02 2022-06-30 Kenjockety Biotechnology, Inc. Efflux Pump-Cancer Antigen Multi-Specific Antibodies and Compositions, Reagents, Kits and Methods Related Thereto
CN110317183B (zh) * 2019-08-08 2021-03-12 无锡紫杉药业有限公司 一种红豆杉天然提取产物的纯化方法
IL293627A (en) 2019-12-12 2022-08-01 Ignite Immunotherapy Inc Variant of oncolytic vaccinia virus and methods of using it
EP4097134A1 (en) 2020-01-29 2022-12-07 Kenjockety Biotechnology, Inc. Anti-mdr1 antibodies and uses thereof
CA3182969A1 (en) 2020-06-04 2021-12-09 Kenjockety Biotechnology, Inc. Abcg2 efflux pump-cancer antigen multi-specific antibodies and compositions, reagents, kits and methods related thereto
EP4161650A1 (en) 2020-06-04 2023-04-12 Kenjockety Biotechnology, Inc. Anti-abcg2 antibodies and uses thereof
BR112023000650A2 (pt) 2020-07-14 2023-01-31 Pfizer Vírus vaccinia recombinante
CN116490522A (zh) 2020-09-02 2023-07-25 肯乔克蒂生物技术股份有限公司 抗abcc1抗体及其应用
US20240010747A1 (en) 2020-11-13 2024-01-11 Kenjockety Biotechnology, Inc. Anti-mrp4 (encoded by abcc4 gene) antibodies and uses thereof
CN112694458A (zh) * 2020-12-29 2021-04-23 重庆臻源红豆杉发展有限公司 一种10-去乙酰基巴卡亭ⅲ提取纯化方法
CA3238353A1 (en) 2021-12-13 2023-06-22 William Robert ARATHOON Anti-abcb1 antibodies
WO2023159220A1 (en) 2022-02-18 2023-08-24 Kenjockety Biotechnology, Inc. Anti-cd47 antibodies

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2629819B1 (fr) 1988-04-06 1990-11-16 Rhone Poulenc Sante Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii
FR2629818B1 (fr) 1988-04-06 1990-11-16 Centre Nat Rech Scient Procede de preparation du taxol
US5175315A (en) 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
US5136060A (en) 1989-11-14 1992-08-04 Florida State University Method for preparation of taxol using an oxazinone
US5380916A (en) 1990-11-02 1995-01-10 University Of Florida Method for the isolation and purification of taxane derivatives
MX9102128A (es) 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
AU1888792A (en) * 1991-04-19 1992-11-17 University Of Mississippi, The Methods and compositions for isolating taxanes
IT1258838B (it) 1992-01-31 1996-02-29 Indena Spa Processo per l'estrazione di tassolo e derivati da cultivar del genere taxus

Also Published As

Publication number Publication date
WO1994007882A1 (fr) 1994-04-14
CA2146373A1 (fr) 1994-04-14
UA44227C2 (uk) 2002-02-15
LV10621B (en) 1995-10-20
CZ287065B6 (cs) 2000-08-16
LTIP1397A (en) 1994-11-25
TW255890B (sk) 1995-09-01
CN1085551A (zh) 1994-04-20
KR100301236B1 (ko) 2001-11-22
EE03126B1 (et) 1998-10-15
CN1043530C (zh) 1999-06-02
PL308244A1 (en) 1995-07-24
CZ84595A3 (en) 1995-09-13
HU9500973D0 (en) 1995-06-28
MX9305771A (es) 1994-05-31
LT3398B (en) 1995-09-25
RU2107065C1 (ru) 1998-03-20
DK0663910T3 (da) 1997-03-10
EP0663910B1 (fr) 1997-02-12
NZ256450A (en) 1996-11-26
ES2098061T3 (es) 1997-04-16
NO951282D0 (no) 1995-04-03
SK43395A3 (en) 1995-08-09
JP3299754B2 (ja) 2002-07-08
RU95110687A (ru) 1996-12-27
CZ284615B6 (cs) 1999-01-13
DE69308155D1 (de) 1997-03-27
DE69308155T2 (de) 1997-08-07
LV10621A (lv) 1995-04-20
FR2696463A1 (fr) 1994-04-08
GR3022617T3 (en) 1997-05-31
HU226862B1 (en) 2009-12-28
JPH08501792A (ja) 1996-02-27
KR950703550A (ko) 1995-09-20
EP0663910A1 (fr) 1995-07-26
FI951596A (fi) 1995-04-04
AU5115593A (en) 1994-04-26
FR2696463B1 (fr) 1994-11-25
FI951596A0 (fi) 1995-04-04
GEP20001937B (en) 2000-02-05
PL177316B1 (pl) 1999-10-29
NO310413B1 (no) 2001-07-02
SK280949B6 (sk) 2000-09-12
CA2146373C (fr) 2006-08-29
AU680629B2 (en) 1997-08-07
FI109794B (fi) 2002-10-15
HUT72449A (en) 1996-04-29
US5393895A (en) 1995-02-28
ATE148883T1 (de) 1997-02-15
NO951282L (no) 1995-04-03

Similar Documents

Publication Publication Date Title
TW255890B (sk)
DK0663909T3 (sk)
HK1007557A1 (en) A process for the extraction of taxol and derivatives thereof from plants of the genus taxus
CA2130745A1 (en) Enhanced production of taxol and taxanes by cell cultures of taxus species
PL327458A1 (en) Intermediate compounds for hemisynthesis if taxanes and method of obtaining them
CA2354847A1 (en) A process for the isolation of 10-deacetyl baccatin iii from the recoverably part of a plant of taxus species
ES2164903T3 (es) Procedimiento de extraccion y de aislamiento de la 10-desacetilbaccatina iii.